Analysis of Clinical Utilization of Levofloxacin Based on Data from Tianjin Medical Insurance

WU Jing,ZHANG Yu-zhe,ZHENG Ya-ming
2010-01-01
Abstract:AIM To analysis the clinical utilization of levofloxacin based on data from Tianjin Medical Insurance in 2007 and to provide policy reference for the rational use and expenditure control of antibacterial agents.METHODS Ten percent of random inpatients samples from Tianjin Employee Basic Medical Insurance (27.8 thousands person-time)in 2007 were collected to analyze the proportions of different formulationes of levofloxacin,as well as the relationship between specification and price and the relationship among dosage, price,and manufacturers.RESULTS More than 95%of the total market share was taken up by i.v.injection; large volume parenteral solution,small volume parenteral solution,and powder for injection occupied 71.84%, 26.79%,and 1.37%of market share of i.v.injection,respectively.There were much price differences between the off-patent brand drugs and the generic drugs and among the different generic drug manufacturers.Even the drugs of the same factory in different specifications had different prices and the difference could as big as 2 times when the prices were conversed to the minimal unit of 0.1 g.It was found that the unit-price had a significantly positive correlation with the quantity(P=0.007 4,correlation coefficient was 0.680 5),which meant the higher the prices were,the more drugs were used.CONCLUSION There is irrational use of levofloxacin in clinical utilization of antibacterial agents and it can be greatly adjusted.The proportions of injection and highprice preparations can be reduced by necessary policy regulating.
What problem does this paper attempt to address?